Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02296801 |
Title | A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer |
Acronym | PALLET |
Recruitment | Completed |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | NSABP Foundation Inc |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | GBR | CAN |